Global Viral Vectors and Plasmid DNA manufacturing Market to reach USD 1507.3 million by 2026

Global Viral Vectors and Plasmid DNA manufacturing Market to reach USD 1507.3 million by 2026 | CAGR: 20.5%

iCrowd Newswire
11 Sep 2019, 01:28 GMT+10

Global Viral Vectors and Plasmid DNA manufacturing Market is valued USD 339.1 million in 2018 is anticipated to grow USD 1507.3 million with the compounded annual growth of 20.5% over the forecast period 2019-2026.

As per the new research study conducted by Report Ocean, Global Viral Vectors and Plasmid DNA manufacturing market industry is poised to raise USD 1507.3 million by 2026. In the present scenario, The gene therapy sector has gained a surging momentum considering the last decade specifically in the research areas which mainly includes vaccination of infectious diseases, Cancer treatment, rare genetic disorders ion both the male and female population on the global scenario. The most regular vector which is being utilized in these gene modification studies mainly include plasmid DNAs and viruses. The utility of viral vectors has been on the surging trend as it being widely adopted by the medical researchers and healthcare experts across the globe. The prevalence of chronic diseases which includes Cancer and Chronic diseases considering both the male and female population is acting as a key driver for the growth and demand of viral vector and Plasmid DNA manufacturing market on the global scenario. For Instance:

According to Canadian Cancer society, an estimated 206,200 new cases of cancer and around 80,800 deaths are caused from cancer occurred in Canada in the year 2017. Cancer is key cause of death considering the male and female population in Canada which is responsible for 30% of all deaths in the country. Moreover, According to Canadian Cancer society, it has been estimated that around 103,100 Canadian male population would be diagnosed with Cancer and around 42,600 male population would die from cancer. In the year 2017, it has been estimated that around 103,200 Canadian female population would be diagnosed with cancer and around 38200 women will die from cancer in the country. On an average around 565 Canadians would be diagnosed with cancer every day in the country & on average around 221 Canadians would die from cancer every day which is further augmenting the growth of Viral vector and Plasmid Dna manufacturing market in the country. Also, The prevalence of cardiovascular diseases mainly in the semi-urban and urban counties of the country is significantly impacting the market growth in United Kingdom. Cardiovascular circulatory and diseases causes around quarter 26 percent of all deaths in United Kingdom which accounts for 160000 deaths every year. On an average occurrence of one death every three minutes. According to British Heart Foundation, around 42000 individual under the age of 75 years in the United Kingdom from Cardiovascular diseases every year which is further fuelling the utility and adoption of viral vector and Plasmid DNA manufacturing market.

To view the summary or to request a sample copy of this report, please click the link mentioned below:

Global Viral Vectors and Plasmid DNA manufacturing Market Size study, by Product (Plasmid DNA, Viral Vectors, Non-Viral Vectors), & by Application (Inherited Disorders, Cancers, Viral Infections, & Others) and Regional Forecasts 2019-2026.

Key findings of the study:

The North American region accounted for the significant market share, more than XX% of the total market in 2018.

The Asia Pacific region will be the highest growing segment with respect to geographical segmentation, the region is likely to grow by XX% CAGR over the forecast period 2019-2026

Report Ocean has considered following segments for the study:

By Type: